000 | 01930 a2200529 4500 | ||
---|---|---|---|
005 | 20250515230137.0 | ||
264 | 0 | _c20101101 | |
008 | 201011s 0 0 eng d | ||
022 | _a1873-2747 | ||
024 | 7 |
_a10.1016/j.brainresbull.2010.06.004 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRoghani, Mehrdad | |
245 | 0 | 0 |
_aOral pelargonidin exerts dose-dependent neuroprotection in 6-hydroxydopamine rat model of hemi-parkinsonism. _h[electronic resource] |
260 |
_bBrain research bulletin _cJul 2010 |
||
300 |
_a279-83 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnthocyanins _xadministration & dosage |
650 | 0 | 4 |
_aAntiparkinson Agents _xpharmacology |
650 | 0 | 4 |
_aApomorphine _xpharmacology |
650 | 0 | 4 |
_aCell Count _xmethods |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 |
_aFunctional Laterality _xdrug effects |
650 | 0 | 4 |
_aLipid Peroxidation _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMesencephalon _xdrug effects |
650 | 0 | 4 |
_aNeurons _xdrug effects |
650 | 0 | 4 |
_aNeuroprotective Agents _xadministration & dosage |
650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
650 | 0 | 4 | _aOxidopamine |
650 | 0 | 4 |
_aParkinsonian Disorders _xchemically induced |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 | _aStatistics, Nonparametric |
650 | 0 | 4 |
_aSuperoxide Dismutase _xmetabolism |
650 | 0 | 4 |
_aThiobarbituric Acid Reactive Substances _xmetabolism |
700 | 1 | _aNiknam, Akram | |
700 | 1 | _aJalali-Nadoushan, Mohammad-Reza | |
700 | 1 | _aKiasalari, Zahra | |
700 | 1 | _aKhalili, Mohsen | |
700 | 1 | _aBaluchnejadmojarad, Tourandokht | |
773 | 0 |
_tBrain research bulletin _gvol. 82 _gno. 5-6 _gp. 279-83 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.brainresbull.2010.06.004 _zAvailable from publisher's website |
999 |
_c19907218 _d19907218 |